Makary Resigns as FDA Commissioner Following Policy Disputes - Takeaways - MDSpire
FDA & Government News

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization

  • By

  • Kathryn Wighton

  • May 12, 2026

  • 2 min

Share

  • 1

    Dr. Marty Makary resigned as FDA Commissioner after 13 months.

  • 2

    His tenure included workforce reductions and turnover among officials.

  • 3

    He opposed pediatric mask mandates during the COVID-19 pandemic.

  • 4

    Makary focused on vaccine policy and food regulation.

  • 5

    His resignation was influenced by Secretary Robert F. Kennedy Jr. with White House approval.

Original Source(s)

Makary Resigns as FDA Commissioner Following Policy Disputes

  • by Kathryn Wighton

  • May 12, 2026

Related Content

Breaking the “Black Box” in Bioprocessing

Why understanding titer analytics is key to faster, more reliable biologics and gene therapy development

  • May 14, 2026

  • 10 min
AI Discharge Summaries Show Low Harm Risk

Most reviewed summaries were rated as posing no harm risk, although omissions remained common.

Uric Acid Stone Dissolution Peaked at pH 7.2

In vitro study found dissolution rates increased sharply above pH 6.5 and were tenfold higher after stone fragmentation.